Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer . Clinics, [S. l.], v. 66, n. 7, p. 1143–1147, 2011. DOI: 10.1590/S1807-59322011000700004. Disponível em: https://revistas.usp.br/clinics/article/view/19352.. Acesso em: 25 may. 2024.